Metastatic Malignant Melanoma Therapy Market, Global Outlook and Forecast 2022-2028

February 2022 | 65 pages | ID: MDFAAC7B96ACEN
Market Monitor Global

Abstracts

Heart metastatic malignant melanoma is the late stage of tumor development.Treatment is mainly to alleviate symptoms and support the treatment of the whole body, such as anemia, edema, hypoproteinemia.For pleural or pericardial effusion should be punctured as soon as possible or catheter drainage, in order to reduce the cardiopulmonary compression.Chemotherapy and immunotherapy can be used in patients with better systemic status, but malignant melanoma is not sensitive to the former, while the latter has a certain effect on enhancing the patient's immunity.Radiotherapy can be used as an experimental therapy and can also confirm the presence or absence of cardiac metastasis.Arrhythmias are sometimes controlled by digitalis therapy.

This report contains market size and forecasts of Metastatic Malignant Melanoma Therapy in Global, including the following market information:

Global Metastatic Malignant Melanoma Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Metastatic Malignant Melanoma Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Immunotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Metastatic Malignant Melanoma Therapy include Merck, Pfizer, Janssen Biotech, Roche, Navidea, Novartis, Bristol-Myers Squibb, Enzon Pharmaceuticals and Exelixis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Metastatic Malignant Melanoma Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Metastatic Malignant Melanoma Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Metastatic Malignant Melanoma Therapy Market Segment Percentages, by Type, 2021 (%)

• Immunotherapy
• Targeted Therapy
• Other

Global Metastatic Malignant Melanoma Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Metastatic Malignant Melanoma Therapy Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Medical Research Organization
• Other

Global Metastatic Malignant Melanoma Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Metastatic Malignant Melanoma Therapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Metastatic Malignant Melanoma Therapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Metastatic Malignant Melanoma Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• Pfizer
• Janssen Biotech
• Roche
• Navidea
• Novartis
• Bristol-Myers Squibb
• Enzon Pharmaceuticals
• Exelixis
• GlaxoSmithKline
• Ono Pharmaceutical
• Amgen

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Metastatic Malignant Melanoma Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Metastatic Malignant Melanoma Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL METASTATIC MALIGNANT MELANOMA THERAPY OVERALL MARKET SIZE

2.1 Global Metastatic Malignant Melanoma Therapy Market Size: 2021 VS 2028
2.2 Global Metastatic Malignant Melanoma Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Metastatic Malignant Melanoma Therapy Players in Global Market
3.2 Top Global Metastatic Malignant Melanoma Therapy Companies Ranked by Revenue
3.3 Global Metastatic Malignant Melanoma Therapy Revenue by Companies
3.4 Top 3 and Top 5 Metastatic Malignant Melanoma Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Metastatic Malignant Melanoma Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Metastatic Malignant Melanoma Therapy Players in Global Market
  3.6.1 List of Global Tier 1 Metastatic Malignant Melanoma Therapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Metastatic Malignant Melanoma Therapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Metastatic Malignant Melanoma Therapy Market Size Markets, 2021 & 2028
  4.1.2 Immunotherapy
  4.1.3 Targeted Therapy
  4.1.4 Other
4.2 By Type - Global Metastatic Malignant Melanoma Therapy Revenue & Forecasts
  4.2.1 By Type - Global Metastatic Malignant Melanoma Therapy Revenue, 2017-2022
  4.2.2 By Type - Global Metastatic Malignant Melanoma Therapy Revenue, 2023-2028
  4.2.3 By Type - Global Metastatic Malignant Melanoma Therapy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Metastatic Malignant Melanoma Therapy Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Medical Research Organization
  5.1.4 Other
5.2 By Application - Global Metastatic Malignant Melanoma Therapy Revenue & Forecasts
  5.2.1 By Application - Global Metastatic Malignant Melanoma Therapy Revenue, 2017-2022
  5.2.2 By Application - Global Metastatic Malignant Melanoma Therapy Revenue, 2023-2028
  5.2.3 By Application - Global Metastatic Malignant Melanoma Therapy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Metastatic Malignant Melanoma Therapy Market Size, 2021 & 2028
6.2 By Region - Global Metastatic Malignant Melanoma Therapy Revenue & Forecasts
  6.2.1 By Region - Global Metastatic Malignant Melanoma Therapy Revenue, 2017-2022
  6.2.2 By Region - Global Metastatic Malignant Melanoma Therapy Revenue, 2023-2028
  6.2.3 By Region - Global Metastatic Malignant Melanoma Therapy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Metastatic Malignant Melanoma Therapy Revenue, 2017-2028
  6.3.2 US Metastatic Malignant Melanoma Therapy Market Size, 2017-2028
  6.3.3 Canada Metastatic Malignant Melanoma Therapy Market Size, 2017-2028
  6.3.4 Mexico Metastatic Malignant Melanoma Therapy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Metastatic Malignant Melanoma Therapy Revenue, 2017-2028
  6.4.2 Germany Metastatic Malignant Melanoma Therapy Market Size, 2017-2028
  6.4.3 France Metastatic Malignant Melanoma Therapy Market Size, 2017-2028
  6.4.4 U.K. Metastatic Malignant Melanoma Therapy Market Size, 2017-2028
  6.4.5 Italy Metastatic Malignant Melanoma Therapy Market Size, 2017-2028
  6.4.6 Russia Metastatic Malignant Melanoma Therapy Market Size, 2017-2028
  6.4.7 Nordic Countries Metastatic Malignant Melanoma Therapy Market Size, 2017-2028
  6.4.8 Benelux Metastatic Malignant Melanoma Therapy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Metastatic Malignant Melanoma Therapy Revenue, 2017-2028
  6.5.2 China Metastatic Malignant Melanoma Therapy Market Size, 2017-2028
  6.5.3 Japan Metastatic Malignant Melanoma Therapy Market Size, 2017-2028
  6.5.4 South Korea Metastatic Malignant Melanoma Therapy Market Size, 2017-2028
  6.5.5 Southeast Asia Metastatic Malignant Melanoma Therapy Market Size, 2017-2028
  6.5.6 India Metastatic Malignant Melanoma Therapy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Metastatic Malignant Melanoma Therapy Revenue, 2017-2028
  6.6.2 Brazil Metastatic Malignant Melanoma Therapy Market Size, 2017-2028
  6.6.3 Argentina Metastatic Malignant Melanoma Therapy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Metastatic Malignant Melanoma Therapy Revenue, 2017-2028
  6.7.2 Turkey Metastatic Malignant Melanoma Therapy Market Size, 2017-2028
  6.7.3 Israel Metastatic Malignant Melanoma Therapy Market Size, 2017-2028
  6.7.4 Saudi Arabia Metastatic Malignant Melanoma Therapy Market Size, 2017-2028
  6.7.5 UAE Metastatic Malignant Melanoma Therapy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck
  7.1.1 Merck Corporate Summary
  7.1.2 Merck Business Overview
  7.1.3 Merck Metastatic Malignant Melanoma Therapy Major Product Offerings
  7.1.4 Merck Metastatic Malignant Melanoma Therapy Revenue in Global Market (2017-2022)
  7.1.5 Merck Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Metastatic Malignant Melanoma Therapy Major Product Offerings
  7.2.4 Pfizer Metastatic Malignant Melanoma Therapy Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Key News
7.3 Janssen Biotech
  7.3.1 Janssen Biotech Corporate Summary
  7.3.2 Janssen Biotech Business Overview
  7.3.3 Janssen Biotech Metastatic Malignant Melanoma Therapy Major Product Offerings
  7.3.4 Janssen Biotech Metastatic Malignant Melanoma Therapy Revenue in Global Market (2017-2022)
  7.3.5 Janssen Biotech Key News
7.4 Roche
  7.4.1 Roche Corporate Summary
  7.4.2 Roche Business Overview
  7.4.3 Roche Metastatic Malignant Melanoma Therapy Major Product Offerings
  7.4.4 Roche Metastatic Malignant Melanoma Therapy Revenue in Global Market (2017-2022)
  7.4.5 Roche Key News
7.5 Navidea
  7.5.1 Navidea Corporate Summary
  7.5.2 Navidea Business Overview
  7.5.3 Navidea Metastatic Malignant Melanoma Therapy Major Product Offerings
  7.5.4 Navidea Metastatic Malignant Melanoma Therapy Revenue in Global Market (2017-2022)
  7.5.5 Navidea Key News
7.6 Novartis
  7.6.1 Novartis Corporate Summary
  7.6.2 Novartis Business Overview
  7.6.3 Novartis Metastatic Malignant Melanoma Therapy Major Product Offerings
  7.6.4 Novartis Metastatic Malignant Melanoma Therapy Revenue in Global Market (2017-2022)
  7.6.5 Novartis Key News
7.7 Bristol-Myers Squibb
  7.7.1 Bristol-Myers Squibb Corporate Summary
  7.7.2 Bristol-Myers Squibb Business Overview
  7.7.3 Bristol-Myers Squibb Metastatic Malignant Melanoma Therapy Major Product Offerings
  7.7.4 Bristol-Myers Squibb Metastatic Malignant Melanoma Therapy Revenue in Global Market (2017-2022)
  7.7.5 Bristol-Myers Squibb Key News
7.8 Enzon Pharmaceuticals
  7.8.1 Enzon Pharmaceuticals Corporate Summary
  7.8.2 Enzon Pharmaceuticals Business Overview
  7.8.3 Enzon Pharmaceuticals Metastatic Malignant Melanoma Therapy Major Product Offerings
  7.8.4 Enzon Pharmaceuticals Metastatic Malignant Melanoma Therapy Revenue in Global Market (2017-2022)
  7.8.5 Enzon Pharmaceuticals Key News
7.9 Exelixis
  7.9.1 Exelixis Corporate Summary
  7.9.2 Exelixis Business Overview
  7.9.3 Exelixis Metastatic Malignant Melanoma Therapy Major Product Offerings
  7.9.4 Exelixis Metastatic Malignant Melanoma Therapy Revenue in Global Market (2017-2022)
  7.9.5 Exelixis Key News
7.10 GlaxoSmithKline
  7.10.1 GlaxoSmithKline Corporate Summary
  7.10.2 GlaxoSmithKline Business Overview
  7.10.3 GlaxoSmithKline Metastatic Malignant Melanoma Therapy Major Product Offerings
  7.10.4 GlaxoSmithKline Metastatic Malignant Melanoma Therapy Revenue in Global Market (2017-2022)
  7.10.5 GlaxoSmithKline Key News
7.11 Ono Pharmaceutical
  7.11.1 Ono Pharmaceutical Corporate Summary
  7.11.2 Ono Pharmaceutical Business Overview
  7.11.3 Ono Pharmaceutical Metastatic Malignant Melanoma Therapy Major Product Offerings
  7.11.4 Ono Pharmaceutical Metastatic Malignant Melanoma Therapy Revenue in Global Market (2017-2022)
  7.11.5 Ono Pharmaceutical Key News
7.12 Amgen
  7.12.1 Amgen Corporate Summary
  7.12.2 Amgen Business Overview
  7.12.3 Amgen Metastatic Malignant Melanoma Therapy Major Product Offerings
  7.12.4 Amgen Metastatic Malignant Melanoma Therapy Revenue in Global Market (2017-2022)
  7.12.5 Amgen Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Metastatic Malignant Melanoma Therapy Market Opportunities & Trends in Global Market
Table 2. Metastatic Malignant Melanoma Therapy Market Drivers in Global Market
Table 3. Metastatic Malignant Melanoma Therapy Market Restraints in Global Market
Table 4. Key Players of Metastatic Malignant Melanoma Therapy in Global Market
Table 5. Top Metastatic Malignant Melanoma Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Metastatic Malignant Melanoma Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Metastatic Malignant Melanoma Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Metastatic Malignant Melanoma Therapy Product Type
Table 9. List of Global Tier 1 Metastatic Malignant Melanoma Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Metastatic Malignant Melanoma Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Metastatic Malignant Melanoma Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Metastatic Malignant Melanoma Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Metastatic Malignant Melanoma Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Metastatic Malignant Melanoma Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Metastatic Malignant Melanoma Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Metastatic Malignant Melanoma Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck Metastatic Malignant Melanoma Therapy Product Offerings
Table 32. Merck Metastatic Malignant Melanoma Therapy Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Metastatic Malignant Melanoma Therapy Product Offerings
Table 35. Pfizer Metastatic Malignant Melanoma Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Janssen Biotech Corporate Summary
Table 37. Janssen Biotech Metastatic Malignant Melanoma Therapy Product Offerings
Table 38. Janssen Biotech Metastatic Malignant Melanoma Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Roche Corporate Summary
Table 40. Roche Metastatic Malignant Melanoma Therapy Product Offerings
Table 41. Roche Metastatic Malignant Melanoma Therapy Revenue (US$, Mn), (2017-2022)
Table 42. Navidea Corporate Summary
Table 43. Navidea Metastatic Malignant Melanoma Therapy Product Offerings
Table 44. Navidea Metastatic Malignant Melanoma Therapy Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Metastatic Malignant Melanoma Therapy Product Offerings
Table 47. Novartis Metastatic Malignant Melanoma Therapy Revenue (US$, Mn), (2017-2022)
Table 48. Bristol-Myers Squibb Corporate Summary
Table 49. Bristol-Myers Squibb Metastatic Malignant Melanoma Therapy Product Offerings
Table 50. Bristol-Myers Squibb Metastatic Malignant Melanoma Therapy Revenue (US$, Mn), (2017-2022)
Table 51. Enzon Pharmaceuticals Corporate Summary
Table 52. Enzon Pharmaceuticals Metastatic Malignant Melanoma Therapy Product Offerings
Table 53. Enzon Pharmaceuticals Metastatic Malignant Melanoma Therapy Revenue (US$, Mn), (2017-2022)
Table 54. Exelixis Corporate Summary
Table 55. Exelixis Metastatic Malignant Melanoma Therapy Product Offerings
Table 56. Exelixis Metastatic Malignant Melanoma Therapy Revenue (US$, Mn), (2017-2022)
Table 57. GlaxoSmithKline Corporate Summary
Table 58. GlaxoSmithKline Metastatic Malignant Melanoma Therapy Product Offerings
Table 59. GlaxoSmithKline Metastatic Malignant Melanoma Therapy Revenue (US$, Mn), (2017-2022)
Table 60. Ono Pharmaceutical Corporate Summary
Table 61. Ono Pharmaceutical Metastatic Malignant Melanoma Therapy Product Offerings
Table 62. Ono Pharmaceutical Metastatic Malignant Melanoma Therapy Revenue (US$, Mn), (2017-2022)
Table 63. Amgen Corporate Summary
Table 64. Amgen Metastatic Malignant Melanoma Therapy Product Offerings
Table 65. Amgen Metastatic Malignant Melanoma Therapy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Metastatic Malignant Melanoma Therapy Segment by Type in 2021
Figure 2. Metastatic Malignant Melanoma Therapy Segment by Application in 2021
Figure 3. Global Metastatic Malignant Melanoma Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Metastatic Malignant Melanoma Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Metastatic Malignant Melanoma Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Metastatic Malignant Melanoma Therapy Revenue in 2021
Figure 8. By Type - Global Metastatic Malignant Melanoma Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Metastatic Malignant Melanoma Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Metastatic Malignant Melanoma Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Metastatic Malignant Melanoma Therapy Revenue Market Share, 2017-2028
Figure 12. US Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Metastatic Malignant Melanoma Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Metastatic Malignant Melanoma Therapy Revenue Market Share, 2017-2028
Figure 24. China Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Metastatic Malignant Melanoma Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Metastatic Malignant Melanoma Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Metastatic Malignant Melanoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Merck Metastatic Malignant Melanoma Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Metastatic Malignant Melanoma Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Janssen Biotech Metastatic Malignant Melanoma Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Roche Metastatic Malignant Melanoma Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Navidea Metastatic Malignant Melanoma Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Metastatic Malignant Melanoma Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bristol-Myers Squibb Metastatic Malignant Melanoma Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Enzon Pharmaceuticals Metastatic Malignant Melanoma Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Exelixis Metastatic Malignant Melanoma Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. GlaxoSmithKline Metastatic Malignant Melanoma Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Ono Pharmaceutical Metastatic Malignant Melanoma Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Amgen Metastatic Malignant Melanoma Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)